Pelthos Therapeutics Q3 EPS $(2.04) Beats $(3.07) Estimate, Sales $15.395M Miss $17.605M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings BeatsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(2.04) per share which beat the analyst consensus estimate of $(3.07) by 33.55 percent. This is a 61.51 percent increase over losses of $(5.30) per share
Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(2.04) per share which beat the analyst consensus estimate of $(3.07) by 33.55 percent. This is a 61.51 percent increase over losses of $(5.30) per share from the same period last year. The company reported quarterly sales of $15.395 million which missed the analyst consensus estimate of $17.605 million by 12.55 percent. This is a 107.87 percent increase over sales of $7.406 million the same period last year.
